Patent
Medicine
Pharma
Health Care at Reasonable Cost: What’s Next?
This episode is audio from the What’s Next? panel from the Engelberg Center’s Hatch-Waxman at 40 and Beyond Symposium. It was recorded on September 27, 2024.
Donald Beers, Office of Chief Counsel of the Food and Drug Administration (FDA) (retired)
Alfred B. Engelberg
Abbe Gluck, Yale Law School
Arti Rai, Duke University School of Law
Ameet Sarpatwari, Harvard Medical School
Michael Weinberg, Engelberg Center on Innovation Law & Policy, NYU School of Law (moderator)